Expression of concern regarding paper by Park et al, published on 25 June 2015: “Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015”, Euro Surveill. 2015;20(25):pii=21169. It has been brought to our attention that some of the authors may not have been informed about the content of the above paper. There is a lack of clarity regarding rights to use the data. The editorial team are investigating what action needs to be taken.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance

In this issue

Home Eurosurveillance Edition  2015: Volume 20/ Issue 18 Article 7
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 20, Issue 18, 07 May 2015
The Americas region declares that rubella has been eliminated
  1. European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

Citation style for this article: Eurosurveillance editorial team. The Americas region declares that rubella has been eliminated. Euro Surveill. 2015;20(18):pii=21120. Available online:

At a Pan American Health Organization/World Health Organization (PAHO/WHO) meeting in April 2015, an international expert committee declared that the Americas region is free of the endemic transmission of rubella [1]. Rubella and congenital rubella syndrome are the third and fourth vaccine-preventable diseases to be eliminated in the Americas, after smallpox (1971) and polio (1994).

The eradication of rubella follows a 15-year initiative which involved widespread vaccination against measles, mumps and rubella (MMR) in the Western Hemisphere.

When contracted in early pregnancy, rubella can cause miscarriage or birth defects.

Read more here.

  1. Pan American Health Organization/World Health Organization (PAHO/WHO). Americas region is declared the world’s first to eliminate rubella. Washington: PAHO; 2015. Available from:

Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.